Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study

The COVID-19 pandemic caused by SARS-CoV-2 has started in December 2019 in Wuhan, China, and become a global health problem. The SARS-COV-2 main protease (Mpro) play a crucial role in the multiplication and control of virus activity. Therefore, we assume that the inhibition of these enzymes inhibits...

Full description

Bibliographic Details
Main Authors:	Moujane Soumia, Zaki Hanane, Moualij Benaissa, Filali Zegzouti Younes, Alem Chakib, Bouachrine Mohammed, Benlyas Mohamed
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	Journal of Taibah University for Science
Subjects:	covid-19 sars-cov2 main protease mpro cysteine protease docking virtual screening asinex database
Online Access:	http://dx.doi.org/10.1080/16583655.2020.1850002

Similar Items

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
by: Asim Kumar Bepari, et al.
Published: (2021-04-01)

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
by: Julia M Flynn, et al.
Published: (2022-06-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction
by: Noémi Miltner, et al.
Published: (2023-02-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
by: Ahmad Alzamami, et al.
Published: (2022-04-01)

Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
by: Samir Chtita, et al.
Published: (2022-10-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Potensi Pendekatan in Silico Sebagai Penghambat Aktivitas Protein Protease Utama SARS-CoV-2 dari Tiga Senyawa Tanaman Obat Jahe Merah
by: Cut Annisa Thahara, et al.
Published: (2022-09-01)

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
by: Moujane Soumia, et al.
Published: (2022-09-01)

Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living Cells
by: Seyed Arad Moghadasi, et al.
Published: (2022-06-01)

Identification and Functional Analysis of a Pseudo-Cysteine Protease from the Midgut Transcriptome of <i>Sphenophorus levis</i>
by: Priscila Yumi Tanaka Shibao, et al.
Published: (2021-10-01)

Determination the binding ability of N-acetyl cysteine and its derivatives with SARS-COV-2 main protease using molecular docking and molecular dynamics studies
by: A. H. Shntaif, et al.
Published: (2021-10-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

Synthetic protein protease sensor platform
by: Ciaran Devoy, et al.
Published: (2024-04-01)

Computational Purposing Phytochemicals against Cysteine Protease of Monkeypox Virus: An In-silico Approach
by: Poonam Bansal, et al.
Published: (2022-12-01)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
by: Rohan R. Narkhede, et al.
Published: (2020-06-01)

A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
by: Titilayo Omolara Johnson, et al.
Published: (2022-06-01)

Cocaprins, β-Trefoil Fold Inhibitors of Cysteine and Aspartic Proteases from <i>Coprinopsis cinerea</i>
by: Miha Renko, et al.
Published: (2022-04-01)

Developing evolution-resistant drugs for COVID-19
by: Daniel M Weinreich
Published: (2022-07-01)

In Silico Study of Secondary Metabolites in Dendrobium spp. as SARS-CoV-2 Antivirus on Main Protease (Mpro)
by: Anggiresti Kinasih, et al.
Published: (2022-03-01)

Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs
by: Lena Parigger, et al.
Published: (2022-12-01)

Roles of Cysteine Proteases in Biology and Pathogenesis of Parasites
by: Nawu Yang, et al.
Published: (2023-05-01)

Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
by: Razie Sabet, et al.
Published: (2021-06-01)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies
by: Sakshi Piplani, et al.
Published: (2022-03-01)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022-06-01)

Extracellular Cysteine Proteases of Key Intestinal Protozoan Pathogens—Factors Linked to Virulence and Pathogenicity
by: Raúl Argüello-García, et al.
Published: (2023-08-01)

Fowlerstefin, a cysteine protease inhibitor of Naegleria fowleri, induces inflammatory responses in BV-2 microglial cells in vitro
by: Thị Lam Thái, et al.
Published: (2020-01-01)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
by: Yongkang Chen, et al.
Published: (2023-01-01)

A cysteine protease from the latex of Ficus benjamina has in vitro anthelmintic activity against Haemonchus contortus
by: Ledia Feitosa Wanderley, et al.
Published: (2018-11-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
by: Suwicha Patnin, et al.
Published: (2022-03-01)

Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814
by: Haihai Jiang, et al.
Published: (2023-08-01)

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking
by: Reina Sasaki-Tanaka, et al.
Published: (2022-05-01)

Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
by: Yow Hui Yin, et al.
Published: (2022-09-01)